Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
Pasquale Paolisso, Luca Bergamaschi, Emanuela Concetta D’Angelo, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
Christopher T. Rentsch, Joshua A. Beckman, Laurie A. Tomlinson, et al.
BMJ (2021), pp. n311-n311
Open Access | Times Cited: 210
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 93
COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Mohamd A. Alblihed, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 92
Lifestyle and Stress Management in Women During COVID-19 Pandemic: Impact on Cardiovascular Risk Burden
Anna Vittoria Mattioli, Susanna Sciomer, Silvia Maffei, et al.
American Journal of Lifestyle Medicine (2020) Vol. 15, Iss. 3, pp. 356-359
Open Access | Times Cited: 75
Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis
Rushad Patell, Thita Chiasakul, Ethan Bauer, et al.
Thrombosis and Haemostasis (2020) Vol. 121, Iss. 01, pp. 076-085
Open Access | Times Cited: 75
The value of ECG changes in risk stratification of COVID‐19 patients
Luca Bergamaschi, Emanuela Concetta D’Angelo, Pasquale Paolisso, et al.
Annals of Noninvasive Electrocardiology (2021) Vol. 26, Iss. 3
Open Access | Times Cited: 67
Polysulfates Block SARS‐CoV‐2 Uptake through Electrostatic Interactions**
Chuanxiong Nie, Paria Pouyan, Daniel Lauster, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 29, pp. 15870-15878
Open Access | Times Cited: 64
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
Charles Tacquard, Alexandre Mansour, Alexandre Godon, et al.
CHEST Journal (2021) Vol. 159, Iss. 6, pp. 2417-2427
Open Access | Times Cited: 63
Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study
Muhammed Elhadi, Ahmed Alsoufi, Abdurraouf Abusalama, et al.
PLoS ONE (2021) Vol. 16, Iss. 4, pp. e0251085-e0251085
Open Access | Times Cited: 59
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
Jamal Majidpoor, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112419-112419
Open Access | Times Cited: 56
Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
Janis K. Shute
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 584-584
Open Access | Times Cited: 21
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction
Raffaele Marfella, Pasquale Paolisso, Celestino Sardu, et al.
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 45
D-Dimer-Driven Anticoagulation Reduces Mortality in Intubated COVID-19 Patients: A Cohort Study With a Propensity-Matched Analysis
Apostolos K. Tassiopoulos, Sima Mofakham, Jerry A. Rubano, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 41
Clinical and electrocardiographic characteristics at admission of COVID-19/SARS-CoV2 pneumonia infection
Andrea Denegri, Giuseppe Pezzuto, Matteo D’Arienzo, et al.
Internal and Emergency Medicine (2021) Vol. 16, Iss. 6, pp. 1451-1456
Open Access | Times Cited: 34
Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update
Antonio Vitiello, Francesco Ferrara
Cardiovascular Drugs and Therapy (2021) Vol. 37, Iss. 2, pp. 277-281
Open Access | Times Cited: 33
Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
Milo Gatti, Fabrizio De Ponti
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 302-302
Open Access | Times Cited: 29
Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis
Mehrdad Rostami, Zahra Khoshnegah, Hassan Mansouritorghabeh
Clinical and Applied Thrombosis/Hemostasis (2021) Vol. 27
Open Access | Times Cited: 28
Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
Chatphatai Moonla, Darintr Sosothikul, Thita Chiasakul, et al.
Clinical and Applied Thrombosis/Hemostasis (2021) Vol. 27, pp. 107602962110089-107602962110089
Open Access | Times Cited: 27
Shear‐Responsive Drug Delivery Systems in Medical Devices: Focus on Thrombosis and Bleeding
Saeedreza Zeibi Shirejini, Josie Carberry, Karen Alt, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 37
Open Access | Times Cited: 11
Insights into neurological dysfunction of critically ill COVID-19 patients
Cristian Deana, Lorenzo Verriello, Giada Pauletto, et al.
Trends in Anaesthesia and Critical Care (2020) Vol. 36, pp. 30-38
Open Access | Times Cited: 31
Prophylaxis and treatment of COVID-19 related venous thromboembolism
Fleur H.J. Kaptein, Milou A.M. Stals, Menno V. Huisman, et al.
Postgraduate Medicine (2021) Vol. 133, Iss. sup1, pp. 27-35
Open Access | Times Cited: 26
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
Sirui Zhang, Yupei Li, Guina Liu, et al.
Thrombosis Journal (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 23
Effects of COVID-19 on Arrhythmia
Yujia Zhan, Honghua Yue, Weitao Liang, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 9, pp. 292-292
Open Access | Times Cited: 14
Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States
Christopher T. Rentsch, Joshua A. Beckman, Laurie A. Tomlinson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 19
Hindrance of the Proteolytic Activity of Neutrophil-Derived Serine Proteases by Serine Protease Inhibitors as a Management of Cardiovascular Diseases and Chronic Inflammation
Timo Burster, Zhadyra Mustafa, Dinara Myrzakhmetova, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top